| Ytd | -97.15% | |
| 1y | -99.02% |
| Open | 0.66 | Prev Close | 0.67 | Low | 0.66 | High | 0.79 | Mkt Cap | 728.81K |
| Vol | 4.46K | Avg Vol | 92.89K | EPS | -302.64 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.38 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 4.36 | 200-d Avg | 18.00 | 1yr Est | 0.00 |
ENvue Medical shares fall after Nasdaq decision as FEED prepares to trade on OTC Markets.
Gainers Tempest Therapeutics (NASDAQ:TPST) stock increased by 41.6% to $1.07 during Tuesday's a
Gainers PDS Biotechnology (NASDAQ:PDSB) shares rose 63.7% to $0.65 during Tuesday's regular ses
TYLER, Texas, Sept. 15, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (Nasdaq: FEED) (“ENvue” or the
ENvue Medical , Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage m
TYLER, Texas, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ENvue Medical , Inc. (NASDAQ: FEED) (“ENvue” or the
Gainers Modular Medical (NASDAQ:MODD) shares increased by 11.3% to $3.14 during Wednesday's pre
Mission Produce rose 5.5% after beating Q3 earnings and sales estimates; several stocks rallied, whi
Gainers InnovAge Holding (NASDAQ:INNV) shares increased by 10.8% to $11.65 during Tuesday's aft
https://x.com/PatentGrants/status/2097414090448887857https://ppubs.uspto.gov/pubwebapp/external.html
ENvue Medical (NASDAQ:FEED) ("ENvue" or the "Company"), a commercial-stage medical d
TYLER, Texas, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ENvue” or the “Compa
ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue" or the "Company"), a commercial-stage med
ENvue Medical (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical
Multi-year agreement with Peak Medical expands UroShield commercialization across the United Kingdom
Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 32.0% to $0.41 during Friday's aft
Gainers ENvue Medical (NASDAQ:FEED) shares rose 49.1% to $0.61 during Wednesday's after-market
TYLER, Texas, Aug. 12, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "
By completing this transition, the Company now manufactures its entire NanoVibronix line in the Unit
TYLER, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ENvue Medical , Inc. (NASDAQ: FEED) (“ENvue” or the
ENvue Medical (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a c
Additional Platform Deployment at Major Academic Medical Center Reflects Increasing Commercial Deman
ENvue Medical (NASDAQ: FEED) ("ENvue," "ENvue Medical" or the "Company"), a
Zeev Rotstein, M.D. Named Chairman Following Four Decades in Health System Leadership, Including 12
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001326706/000149315226033191/form8-k.htm
Gainers Pulsenmore (NASDAQ:PLSM) shares increased by 171.2% to $10.47 during Monday's pre-marke
ENvue Medical, Inc. (NASDAQ:FEED) announced Thursday the development and demonstration of the protot
ENvue Medical demonstrated its ENvue Drive prototype, combining AI, real-time navigation and robotic
ENvue Targeting Combined $10 Billion+ Enteral Feeding and Vascular Access Market Opportunity* ENvue
MANAUS, Brazil, June 17, 2026 (GLOBE NEWSWIRE) -- Brazil Potash Corp. (“Brazil Potash” or the “Compa
NEWARK, Calif. & WARSAW, Poland--(BUSINESS WIRE)-- #EnergyIndependence--Ohmium International Inc., a
AI-based platform, ‘Ask Oscar™', to accelerate adoption of ENvue's Navigation Platform and e
AI-based platform, ‘Ask Oscar™', to accelerate adoption of ENvue's Navigation Platform and enable cl
ENvue Medical (NASDAQ:FEED) ("ENvue," "ENvue Medical," or the "Company"), a
Second ENvue Navigation Platform Deployed Within the Same Health System Reflects the Clinical Confid
Independent, Peer-Reviewed Study Demonstrated Significant Improvement in Patient Outcomes, Reduction
Independent, Peer-Reviewed Study Demonstrated Significant Improvement in Patient Outcomes, Reduction
Shares of 8x8 Inc (NASDAQ: EGHT) jumped 13.3% in pre-market trading after reporting better-than-expe
TYLER, Texas, May 19, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ENvue,” “ENvue Medical
ENvue Medical (NASDAQ:FEED) reported quarterly losses of $(6.88) per share. This is a 76.99 percent
ENvue™ Navigation Platform adopted as the standard of care for bedside feeding tube placement across
ENvue Medical secured a three-year renewal with a 12-hospital health system, extending its feeding t
ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"
Patent Expands Company's Proprietary Surface Acoustic Wave Platform into Advanced Therapeutic Delive
Renewed agreement provides streamlined access to ENvue equipment and supplies across a network of mo
ENvue Medical renewed a three-year purchasing agreement covering 90-plus hospitals across 17 states
MANAUS, Brazil, May 06, 2026 (GLOBE NEWSWIRE) -- Brazil Potash Corp. (“Brazil Potash” or the “Compan
ENvue Medical shares slip premarket on Thursday after rally as Detroit hospital purchase lifts adopt